<!DOCTYPE html>
<html lang="tr">
<head>
<link rel="icon" type="image/png" sizes="32x32" href="/favicon.png"><link rel="icon" type="image/png" sizes="16x16" href="/favicon-16.png">
<script src="/scripts/https-redirect.js"></script>
<!-- Google tag (gtag.js) -->
<script async src="https://www.googletagmanager.com/gtag/js?id=G-QBM7E0EHFP"></script>
<script>
 window.dataLayer = window.dataLayer || [];
 function gtag(){dataLayer.push(arguments);}
 gtag('js', new Date());
 gtag('config', 'G-QBM7E0EHFP');
</script>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>GLP-1 Ä°laÃ§ KarÅŸÄ±laÅŸtÄ±rma AracÄ± | UzunYaÅŸa</title>
<meta name="description" content="GLP-1 ilaÃ§larÄ±nÄ± karÅŸÄ±laÅŸtÄ±rÄ±n: Wegovy, Ozempic, Mounjaro, Zepbound, Saxenda ve yeni nesil oral ilaÃ§lar. Etkinlik, dozaj, yan etki ve fiyat karÅŸÄ±laÅŸtÄ±rmasÄ±.">
<link rel="canonical" href="https://uzunyasa.com/pages/araclar/glp1-karsilastirma.html">
<meta property="og:title" content="GLP-1 Ä°laÃ§ KarÅŸÄ±laÅŸtÄ±rma AracÄ± | UzunYaÅŸa">
<meta property="og:description" content="7 GLP-1 ilacÄ±nÄ± yan yana karÅŸÄ±laÅŸtÄ±rÄ±n. Hangisi size uygun? Ä°nteraktif karÅŸÄ±laÅŸtÄ±rma aracÄ±.">
<meta property="og:image" content="https://uzunyasa.com/images/og-default.png">
<meta property="og:url" content="https://uzunyasa.com/pages/araclar/glp1-karsilastirma.html">
<meta property="og:type" content="website">
<meta property="og:locale" content="tr_TR">
<link rel="preconnect" href="https://fonts.googleapis.com">
<link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
<link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800;900&family=Playfair+Display:wght@700&display=swap" rel="stylesheet">
<style>
:root{--primary:#0D7377;--dark:#195157;--accent:#E8963E;--bg:#f8fafa;--card:#fff;--gray-50:#f9fafb;--gray-100:#f3f4f6;--gray-200:#e5e7eb;--gray-400:#9ca3af;--gray-500:#6b7280;--gray-700:#374151;--gray-900:#111827;--radius:16px;--shadow:0 4px 24px rgba(0,0,0,.08);--green:#10B981;--blue:#3B82F6;--purple:#8B5CF6;--red:#EF4444;--pink:#EC4899;--orange:#F59E0B}
*{margin:0;padding:0;box-sizing:border-box}
body{font-family:'Inter',system-ui,sans-serif;background:var(--bg);color:var(--gray-700);line-height:1.6;min-height:100vh;display:flex;flex-direction:column}

/* Header */
.site-header{background:#fff;border-bottom:1px solid var(--gray-200);padding:.875rem 1.5rem;position:sticky;top:0;z-index:100;display:flex;align-items:center;justify-content:space-between}
.site-header a{text-decoration:none;display:flex;align-items:center;gap:.5rem}
.logo-text{font-family:'Playfair Display',serif;font-size:1.35rem;font-weight:700;color:var(--dark)}
.logo-text span{color:var(--accent)}
.back-link{font-size:.875rem;color:var(--primary);font-weight:600;text-decoration:none;display:flex;align-items:center;gap:.25rem}

/* Main */
.main-wrap{max-width:1080px;margin:0 auto;padding:1.5rem 1rem;width:100%;flex:1}

/* Hero */
.hero-card{background:linear-gradient(135deg,var(--primary),#14919B);border-radius:var(--radius);padding:2.5rem 2rem;color:#fff;text-align:center;margin-bottom:2rem}
.hero-card h1{font-family:'Playfair Display',serif;font-size:2rem;margin-bottom:.75rem}
.hero-card p{opacity:.9;max-width:600px;margin:0 auto;font-size:1rem}

/* Filters */
.filters{display:flex;gap:.5rem;flex-wrap:wrap;justify-content:center;margin-bottom:1.5rem}
.filter-btn{padding:.5rem 1.25rem;border-radius:99px;border:2px solid var(--gray-200);background:#fff;color:var(--gray-500);font-size:.85rem;font-weight:600;cursor:pointer;transition:all .2s;font-family:inherit}
.filter-btn:hover{border-color:var(--primary);color:var(--primary)}
.filter-btn.active{background:var(--primary);color:#fff;border-color:var(--primary)}

/* Compare bar */
.compare-bar{background:#fff;border:2px solid var(--primary);border-radius:12px;padding:1rem 1.5rem;margin-bottom:1.5rem;display:flex;align-items:center;justify-content:space-between;flex-wrap:wrap;gap:.75rem}
.compare-bar .label{font-weight:700;color:var(--dark);font-size:.95rem}
.compare-bar .selected-drugs{display:flex;gap:.5rem;flex-wrap:wrap}
.compare-bar .drug-tag{background:var(--primary);color:#fff;padding:.35rem .85rem;border-radius:99px;font-size:.8rem;font-weight:600;display:inline-flex;align-items:center;gap:.35rem}
.compare-bar .drug-tag .remove{cursor:pointer;opacity:.7;font-size:1.1rem}
.compare-bar .drug-tag .remove:hover{opacity:1}
.compare-btn{padding:.6rem 1.5rem;border-radius:99px;border:none;background:var(--accent);color:#fff;font-weight:700;cursor:pointer;font-family:inherit;font-size:.9rem;transition:all .2s}
.compare-btn:hover{filter:brightness(1.1);transform:translateY(-1px)}
.compare-btn:disabled{opacity:.4;cursor:not-allowed;transform:none}

/* Drug cards grid */
.drugs-grid{display:grid;grid-template-columns:repeat(auto-fill,minmax(300px,1fr));gap:1.25rem;margin-bottom:2rem}

/* Drug card */
.drug-card{background:var(--card);border-radius:var(--radius);box-shadow:var(--shadow);overflow:hidden;border:2px solid transparent;transition:all .3s;cursor:pointer;position:relative}
.drug-card:hover{transform:translateY(-4px);box-shadow:0 8px 32px rgba(0,0,0,.12)}
.drug-card.selected{border-color:var(--primary);box-shadow:0 0 0 3px rgba(13,115,119,.15)}
.drug-card.hidden{display:none}
.card-top{padding:1.25rem 1.25rem .75rem;position:relative}
.card-status{position:absolute;top:1rem;right:1rem;padding:.25rem .75rem;border-radius:99px;font-size:.7rem;font-weight:700;text-transform:uppercase;letter-spacing:.5px}
.card-status.approved{background:#D1FAE5;color:#065F46}
.card-status.pipeline{background:#FEF3C7;color:#92400E}
.drug-type-badge{display:inline-block;padding:.2rem .65rem;border-radius:99px;font-size:.7rem;font-weight:700;margin-bottom:.5rem}
.drug-name{font-size:1.25rem;font-weight:800;color:var(--dark);margin-bottom:.15rem}
.drug-brand{font-size:.85rem;color:var(--gray-500);margin-bottom:.75rem}
.stats-row{display:flex;gap:.75rem;flex-wrap:wrap;margin-bottom:.5rem}
.stat-pill{background:var(--gray-50);padding:.4rem .75rem;border-radius:8px;font-size:.8rem;display:flex;align-items:center;gap:.35rem}
.stat-pill .num{font-weight:800;color:var(--dark)}
.stat-pill .lbl{color:var(--gray-500);font-size:.75rem}
.card-details{padding:0 1.25rem 1.25rem}
.detail-row{display:flex;justify-content:space-between;padding:.5rem 0;border-bottom:1px solid var(--gray-100);font-size:.85rem}
.detail-row:last-child{border-bottom:none}
.detail-row .key{color:var(--gray-500)}
.detail-row .val{font-weight:600;color:var(--dark);text-align:right;max-width:60%}
.select-check{position:absolute;top:1rem;left:1rem;width:24px;height:24px;border-radius:50%;border:2px solid var(--gray-200);display:flex;align-items:center;justify-content:center;transition:all .2s;background:#fff}
.drug-card.selected .select-check{background:var(--primary);border-color:var(--primary);color:#fff}

/* Comparison table */
.compare-section{display:none;margin-bottom:2rem}
.compare-section.show{display:block}
.compare-table-wrap{overflow-x:auto;-webkit-overflow-scrolling:touch}
.compare-table{width:100%;border-collapse:separate;border-spacing:0;background:#fff;border-radius:var(--radius);overflow:hidden;box-shadow:var(--shadow)}
.compare-table th{background:var(--primary);color:#fff;padding:.85rem 1rem;font-size:.85rem;font-weight:700;text-align:left;position:sticky;top:0}
.compare-table td{padding:.75rem 1rem;font-size:.85rem;border-bottom:1px solid var(--gray-100);vertical-align:top}
.compare-table tr:last-child td{border-bottom:none}
.compare-table tr:hover td{background:rgba(13,115,119,.03)}
.compare-table .row-label{font-weight:700;color:var(--dark);background:var(--gray-50);min-width:140px}
.winner{background:rgba(16,185,129,.08) !important;font-weight:700;color:#065F46}

/* Quiz */
.quiz-section{background:#fff;border-radius:var(--radius);box-shadow:var(--shadow);padding:2rem;margin-bottom:2rem}
.quiz-section h2{font-family:'Playfair Display',serif;font-size:1.5rem;color:var(--dark);margin-bottom:.5rem;text-align:center}
.quiz-section p.subtitle{color:var(--gray-500);text-align:center;margin-bottom:1.5rem}
.quiz-step{display:none}
.quiz-step.active{display:block}
.quiz-q{font-size:1.1rem;font-weight:700;color:var(--dark);margin-bottom:1rem}
.quiz-options{display:grid;gap:.75rem}
.quiz-opt{padding:1rem 1.25rem;border:2px solid var(--gray-200);border-radius:12px;cursor:pointer;transition:all .2s;font-size:.95rem;display:flex;align-items:center;gap:.75rem}
.quiz-opt:hover{border-color:var(--primary);background:rgba(13,115,119,.03)}
.quiz-opt.chosen{border-color:var(--primary);background:rgba(13,115,119,.08)}
.quiz-opt .emoji{font-size:1.5rem}
.quiz-result{text-align:center;padding:1.5rem}
.quiz-result h3{font-size:1.3rem;color:var(--dark);margin-bottom:.5rem}
.quiz-result .rec-drug{font-size:1.5rem;font-weight:900;color:var(--primary);margin:.75rem 0}
.quiz-result .rec-reason{color:var(--gray-500);max-width:500px;margin:0 auto 1rem}
.quiz-nav{display:flex;justify-content:center;gap:1rem;margin-top:1.5rem}
.quiz-nav button{padding:.6rem 1.5rem;border-radius:99px;border:none;font-weight:700;cursor:pointer;font-family:inherit;font-size:.9rem;transition:all .2s}
.quiz-nav .next-btn{background:var(--primary);color:#fff}
.quiz-nav .next-btn:hover{background:var(--dark)}
.quiz-nav .restart-btn{background:var(--gray-100);color:var(--gray-700)}

/* Sources */
.sources-section{background:#fff;border-radius:var(--radius);padding:1.5rem;margin-bottom:1.5rem}
.sources-section h3{font-size:1rem;color:var(--dark);margin-bottom:.75rem}
.sources-section ul{list-style:none;padding:0}
.sources-section li{font-size:.8rem;color:var(--gray-500);margin-bottom:.4rem;padding-left:1rem;position:relative}
.sources-section li::before{content:'â€¢';position:absolute;left:0;color:var(--primary)}

/* Disclaimer */
.disclaimer{background:#FEF3C7;border:1px solid #F59E0B;border-radius:12px;padding:1.25rem;font-size:.85rem;color:#92400E;margin-bottom:2rem}
.disclaimer strong{color:#78350F}

/* Footer */
.site-footer{background:var(--dark);color:rgba(255,255,255,.7);text-align:center;padding:2rem 1.5rem;font-size:.8rem;margin-top:auto}
.site-footer a{color:var(--accent);text-decoration:none}

/* Color coding for drug types */
.type-glp1{background:rgba(16,185,129,.15);color:#065F46}
.type-dual{background:rgba(139,92,246,.15);color:#5B21B6}
.type-triple{background:rgba(236,72,153,.15);color:#9D174D}
.type-oral{background:rgba(59,130,246,.15);color:#1E40AF}

@media(max-width:640px){
 .hero-card h1{font-size:1.5rem}
 .hero-card{padding:1.75rem 1.25rem}
 .drugs-grid{grid-template-columns:1fr}
 .compare-bar{flex-direction:column;text-align:center}
}
</style>
<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "WebApplication",
  "name": "GLP-1 Ä°laÃ§ KarÅŸÄ±laÅŸtÄ±rma AracÄ± | UzunYaÅŸa",
  "description": "GLP-1 ilaÃ§larÄ±nÄ± karÅŸÄ±laÅŸtÄ±rÄ±n: Wegovy, Ozempic, Mounjaro, Zepbound, Saxenda ve yeni nesil oral ilaÃ§lar. Etkinlik, dozaj, yan etki ve fiyat karÅŸÄ±laÅŸtÄ±rmasÄ±.",
  "url": "https://uzunyasa.com/pages/araclar/glp1-karsilastirma.html",
  "applicationCategory": "HealthApplication",
  "operatingSystem": "Web",
  "offers": {
    "@type": "Offer",
    "price": "0",
    "priceCurrency": "TRY"
  },
  "author": {
    "@type": "Organization",
    "name": "UzunYaÅŸa",
    "url": "https://uzunyasa.com"
  },
  "image": "https://uzunyasa.com/images/og-default.png"
}
</script>
</head>
<body>

<header class="site-header">
 <a href="/index.html">
  <span class="logo-text">Uzun<span>YaÅŸa</span></span>
 </a>
 <a href="/pages/araclar.html" class="back-link">â† AraÃ§lar</a>
</header>

<div class="main-wrap">

<!-- Hero -->
<div class="hero-card">
 <h1>ğŸ’Š GLP-1 Ä°laÃ§ KarÅŸÄ±laÅŸtÄ±rma</h1>
 <p>OnaylÄ± ve geliÅŸtirme aÅŸamasÄ±ndaki GLP-1 ilaÃ§larÄ±nÄ± yan yana karÅŸÄ±laÅŸtÄ±rÄ±n. Etkinlik, dozaj, yan etki ve kalp saÄŸlÄ±ÄŸÄ± verileri.</p>
</div>

<!-- Filters -->
<div class="filters">
 <button class="filter-btn active" data-filter="all" onclick="filterDrugs('all',this)">ğŸ”¬ TÃ¼mÃ¼</button>
 <button class="filter-btn" data-filter="approved" onclick="filterDrugs('approved',this)">âœ… OnaylÄ±</button>
 <button class="filter-btn" data-filter="pipeline" onclick="filterDrugs('pipeline',this)">ğŸ§ª GeliÅŸtirmede</button>
 <button class="filter-btn" data-filter="injection" onclick="filterDrugs('injection',this)">ğŸ’‰ Enjeksiyon</button>
 <button class="filter-btn" data-filter="oral" onclick="filterDrugs('oral',this)">ğŸ’Š Oral</button>
</div>

<!-- Compare bar -->
<div class="compare-bar" id="compareBar">
 <div>
  <div class="label">ğŸ“Š KarÅŸÄ±laÅŸtÄ±r (2-3 ilaÃ§ seÃ§in)</div>
  <div class="selected-drugs" id="selectedDrugs"></div>
 </div>
 <button class="compare-btn" id="compareBtn" disabled onclick="showComparison()">KarÅŸÄ±laÅŸtÄ±r â†’</button>
</div>

<!-- Drug Cards -->
<div class="drugs-grid" id="drugsGrid"></div>

<!-- Comparison Table -->
<div class="compare-section" id="compareSection">
 <h2 style="font-family:'Playfair Display',serif;font-size:1.5rem;color:var(--dark);margin-bottom:1rem;text-align:center">ğŸ“Š DetaylÄ± KarÅŸÄ±laÅŸtÄ±rma</h2>
 <div class="compare-table-wrap">
  <table class="compare-table" id="compareTable"></table>
 </div>
 <div style="text-align:center;margin-top:1rem">
  <button class="compare-btn" onclick="hideComparison()" style="background:var(--gray-500)">âœ• KarÅŸÄ±laÅŸtÄ±rmayÄ± Kapat</button>
 </div>
</div>

<!-- Quiz: Hangisi Bana Uygun? -->
<div class="quiz-section" id="quizSection">
 <h2>ğŸ¯ Hangisi Bana Uygun?</h2>
 <p class="subtitle">4 basit soru ile size en uygun GLP-1 ilacÄ±nÄ± bulun</p>

 <div class="quiz-step active" data-step="1">
  <div class="quiz-q">1. Enjeksiyon yapmakla ilgili ne dÃ¼ÅŸÃ¼nÃ¼yorsunuz?</div>
  <div class="quiz-options">
   <div class="quiz-opt" onclick="quizAnswer(1,'ok')"><span class="emoji">ğŸ’‰</span>Sorun deÄŸil, haftada bir yapabilirim</div>
   <div class="quiz-opt" onclick="quizAnswer(1,'daily-ok')"><span class="emoji">ğŸ’‰</span>GÃ¼nlÃ¼k enjeksiyon da olabilir</div>
   <div class="quiz-opt" onclick="quizAnswer(1,'no')"><span class="emoji">ğŸ’Š</span>Hap tercih ederim, enjeksiyon istemiyorum</div>
  </div>
 </div>

 <div class="quiz-step" data-step="2">
  <div class="quiz-q">2. Birincil hedefiniz nedir?</div>
  <div class="quiz-options">
   <div class="quiz-opt" onclick="quizAnswer(2,'max-loss')"><span class="emoji">âš–ï¸</span>Maksimum kilo kaybÄ±</div>
   <div class="quiz-opt" onclick="quizAnswer(2,'moderate')"><span class="emoji">ğŸ¯</span>Orta dÃ¼zey kilo kaybÄ± + diyabet kontrolÃ¼</div>
   <div class="quiz-opt" onclick="quizAnswer(2,'heart')"><span class="emoji">â¤ï¸</span>Kalp saÄŸlÄ±ÄŸÄ± koruma</div>
  </div>
 </div>

 <div class="quiz-step" data-step="3">
  <div class="quiz-q">3. FDA onaylÄ±, kullanÄ±ma hazÄ±r bir ilaÃ§ mÄ± tercih edersiniz?</div>
  <div class="quiz-options">
   <div class="quiz-opt" onclick="quizAnswer(3,'approved')"><span class="emoji">âœ…</span>Evet, sadece onaylÄ± ilaÃ§lar</div>
   <div class="quiz-opt" onclick="quizAnswer(3,'open')"><span class="emoji">ğŸ§ª</span>Klinik Ã§alÄ±ÅŸma aÅŸamasÄ±ndakilere de aÃ§Ä±ÄŸÄ±m</div>
  </div>
 </div>

 <div class="quiz-step" data-step="4">
  <div class="quiz-q">4. BÃ¼tÃ§e tercihiniz?</div>
  <div class="quiz-options">
   <div class="quiz-opt" onclick="quizAnswer(4,'budget')"><span class="emoji">ğŸ’°</span>Uygun fiyat Ã¶nemli</div>
   <div class="quiz-opt" onclick="quizAnswer(4,'mid')"><span class="emoji">ğŸ’³</span>Orta bÃ¼tÃ§e</div>
   <div class="quiz-opt" onclick="quizAnswer(4,'premium')"><span class="emoji">ğŸ’</span>En iyi sonuÃ§ iÃ§in bÃ¼tÃ§e sorun deÄŸil</div>
  </div>
 </div>

 <div class="quiz-step" data-step="result">
  <div class="quiz-result" id="quizResult"></div>
 </div>
</div>

<!-- Sources -->
<div class="sources-section">
 <h3>ğŸ“š Kaynaklar</h3>
 <ul>
  <li>Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). NEJM. 2021;384:989-1002.</li>
  <li>Lincoff AM, et al. Semaglutide and Cardiovascular Outcomes in Obesity (SELECT). NEJM. 2023;389:2221-2232.</li>
  <li>Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). NEJM. 2022;387:205-216.</li>
  <li>Aronne LJ, et al. Orforglipron in Obesity (ATTAIN-1). Lancet. 2024;403:2685-2698.</li>
  <li>Jastreboff AM, et al. Retatrutide in Obesity (Phase 2 Trial). NEJM. 2023;389:514-526.</li>
  <li>FDA Oral Semaglutide Approval for Obesity. FDA.gov. 2025.</li>
  <li>Pi-Sunyer X, et al. Liraglutide for Weight Management (SCALE). NEJM. 2015;373:11-22.</li>
 </ul>
</div>

<!-- Disclaimer -->
<div class="disclaimer">
 <strong>âš ï¸ TÄ±bbi UyarÄ±:</strong> Bu araÃ§ yalnÄ±zca bilgilendirme amaÃ§lÄ±dÄ±r ve tÄ±bbi tavsiye yerine geÃ§mez. Ä°laÃ§ seÃ§imi mutlaka bir hekim tarafÄ±ndan yapÄ±lmalÄ±dÄ±r. Kendi kendinize ilaÃ§ baÅŸlamayÄ±n veya deÄŸiÅŸtirmeyin. Buradaki veriler klinik Ã§alÄ±ÅŸma ortalamalarÄ± olup bireysel sonuÃ§lar farklÄ±lÄ±k gÃ¶sterebilir.
</div>

</div><!-- /main-wrap -->

<footer class="site-footer">
 <p>Â© 2026 UzunYaÅŸa â€” SaÄŸlÄ±klÄ± yaÅŸam rehberiniz</p>
 <p style="margin-top:.5rem"><a href="/pages/gizlilik-politikasi.html">Gizlilik</a> Â· <a href="/pages/kullanim-sartlari.html">KullanÄ±m ÅartlarÄ±</a> Â· <a href="/pages/hakkimizda.html">HakkÄ±mÄ±zda</a></p>
</footer>

<script>
// â”€â”€ DRUG DATA â”€â”€
const DRUGS = [
 {
  id:'sema24',name:'Semaglutide 2.4mg',brand:'Wegovy',type:'GLP-1',typeClass:'type-glp1',
  weightLoss:'~15%',dosing:'Haftada 1 enjeksiyon',fdaStatus:'OnaylÄ±',statusClass:'approved',
  heartBenefit:'SELECT: -%20 MACE',route:'injection',phase:'approved',
  mechanism:'GLP-1 reseptÃ¶r agonisti',onset:'4-8 hafta',peakLoss:'68 hafta',
  commonSE:'BulantÄ± (%44), diyare (%30), kusma (%24)',seriousSE:'Pankreatit (nadir), safra taÅŸÄ±',
  contraindications:'MEN2, medÃ¼ller tiroid kanseri Ã¶ykÃ¼sÃ¼',
  trialName:'STEP 1-4, SELECT',participants:'17,604 (SELECT)',
  costUS:'~$1,350/ay',costTR:'HenÃ¼z SGK kapsamÄ±nda deÄŸil'
 },
 {
  id:'sema1',name:'Semaglutide 1mg',brand:'Ozempic',type:'GLP-1',typeClass:'type-glp1',
  weightLoss:'~12%',dosing:'Haftada 1 enjeksiyon',fdaStatus:'OnaylÄ± (diyabet)',statusClass:'approved',
  heartBenefit:'Evet (SUSTAIN-6)',route:'injection',phase:'approved',
  mechanism:'GLP-1 reseptÃ¶r agonisti',onset:'4-8 hafta',peakLoss:'52 hafta',
  commonSE:'BulantÄ± (%40), diyare (%22), kusma (%15)',seriousSE:'Pankreatit (nadir)',
  contraindications:'MEN2, medÃ¼ller tiroid kanseri Ã¶ykÃ¼sÃ¼',
  trialName:'SUSTAIN 1-10',participants:'9,901 (SUSTAIN-6)',
  costUS:'~$900/ay',costTR:'SGK (diyabet endikasyonu)'
 },
 {
  id:'oral-sema',name:'Oral Semaglutide',brand:'Oral Wegovy (Rybelsus 50mg)',type:'GLP-1 (Oral)',typeClass:'type-oral',
  weightLoss:'~15%',dosing:'GÃ¼nlÃ¼k 1 hap',fdaStatus:'OnaylÄ± (2025)',statusClass:'approved',
  heartBenefit:'AraÅŸtÄ±rÄ±lÄ±yor',route:'oral',phase:'approved',
  mechanism:'Oral GLP-1 reseptÃ¶r agonisti (SNAC teknolojisi)',onset:'4-8 hafta',peakLoss:'68 hafta',
  commonSE:'BulantÄ± (%40), diyare (%25), kusma (%20)',seriousSE:'Pankreatit (nadir)',
  contraindications:'MEN2, medÃ¼ller tiroid kanseri Ã¶ykÃ¼sÃ¼',
  trialName:'OASIS 1-4',participants:'3,600+ (OASIS)',
  costUS:'~$1,200/ay',costTR:'HenÃ¼z mevcut deÄŸil'
 },
 {
  id:'tirze',name:'Tirzepatide',brand:'Mounjaro / Zepbound',type:'GLP-1/GIP',typeClass:'type-dual',
  weightLoss:'~20-22%',dosing:'Haftada 1 enjeksiyon',fdaStatus:'OnaylÄ±',statusClass:'approved',
  heartBenefit:'SURPASS-CVOT devam ediyor',route:'injection',phase:'approved',
  mechanism:'Ã‡ift agonist: GLP-1 + GIP reseptÃ¶rleri',onset:'4-8 hafta',peakLoss:'72 hafta',
  commonSE:'BulantÄ± (%31), diyare (%23), kusma (%12)',seriousSE:'Pankreatit (nadir), safra taÅŸÄ±',
  contraindications:'MEN2, medÃ¼ller tiroid kanseri Ã¶ykÃ¼sÃ¼',
  trialName:'SURMOUNT 1-4, SURPASS',participants:'2,539 (SURMOUNT-1)',
  costUS:'~$1,060/ay',costTR:'HenÃ¼z TÃ¼rkiye\'de yok'
 },
 {
  id:'retat',name:'Retatrutide',brand:'TBD (Eli Lilly)',type:'GLP-1/GIP/Glukagon',typeClass:'type-triple',
  weightLoss:'~24%',dosing:'Haftada 1 enjeksiyon',fdaStatus:'Faz 3',statusClass:'pipeline',
  heartBenefit:'AraÅŸtÄ±rÄ±lÄ±yor',route:'injection',phase:'pipeline',
  mechanism:'ÃœÃ§lÃ¼ agonist: GLP-1 + GIP + Glukagon reseptÃ¶rleri',onset:'4-12 hafta',peakLoss:'48 hafta (Faz 2)',
  commonSE:'BulantÄ± (%26), diyare (%22), kusma (%13)',seriousSE:'Faz 3 verileri bekleniyor',
  contraindications:'Faz 3 verileri bekleniyor',
  trialName:'Faz 2 (NCT05929066)',participants:'338 (Faz 2)',
  costUS:'HenÃ¼z belirsiz',costTR:'HenÃ¼z mevcut deÄŸil'
 },
 {
  id:'orfor',name:'Orforglipron',brand:'TBD (Eli Lilly)',type:'Oral GLP-1',typeClass:'type-oral',
  weightLoss:'~14%',dosing:'GÃ¼nlÃ¼k 1 hap',fdaStatus:'Faz 3',statusClass:'pipeline',
  heartBenefit:'AraÅŸtÄ±rÄ±lÄ±yor',route:'oral',phase:'pipeline',
  mechanism:'Oral kÃ¼Ã§Ã¼k molekÃ¼l GLP-1 agonisti (peptid deÄŸil)',onset:'4-8 hafta',peakLoss:'36 hafta (Faz 2)',
  commonSE:'BulantÄ± (%40), kusma (%21), diyare (%18)',seriousSE:'Faz 3 verileri bekleniyor',
  contraindications:'Faz 3 verileri bekleniyor',
  trialName:'ATTAIN-1, ATTAIN-2',participants:'1,200+ (ATTAIN)',
  costUS:'HenÃ¼z belirsiz',costTR:'HenÃ¼z mevcut deÄŸil'
 },
 {
  id:'lira',name:'Liraglutide 3mg',brand:'Saxenda',type:'GLP-1',typeClass:'type-glp1',
  weightLoss:'~8%',dosing:'GÃ¼nlÃ¼k 1 enjeksiyon',fdaStatus:'OnaylÄ±',statusClass:'approved',
  heartBenefit:'Orta (LEADER Ã§alÄ±ÅŸmasÄ±)',route:'injection',phase:'approved',
  mechanism:'GLP-1 reseptÃ¶r agonisti',onset:'2-4 hafta',peakLoss:'56 hafta',
  commonSE:'BulantÄ± (%39), diyare (%21), kabÄ±zlÄ±k (%19)',seriousSE:'Pankreatit (nadir)',
  contraindications:'MEN2, medÃ¼ller tiroid kanseri Ã¶ykÃ¼sÃ¼',
  trialName:'SCALE 1-4, LEADER',participants:'3,731 (SCALE)',
  costUS:'~$1,400/ay',costTR:'SGK dÄ±ÅŸÄ±, ~â‚º3,000-4,000/ay'
 }
];

let selectedIds = [];
let currentFilter = 'all';

// â”€â”€ RENDER CARDS â”€â”€
function renderCards() {
 const grid = document.getElementById('drugsGrid');
 grid.innerHTML = DRUGS.map(d => {
  const isSelected = selectedIds.includes(d.id);
  const hidden = shouldHide(d);
  return `
   <div class="drug-card ${isSelected ? 'selected' : ''} ${hidden ? 'hidden' : ''}" data-id="${d.id}" onclick="toggleSelect('${d.id}')">
    <div class="select-check">${isSelected ? 'âœ“' : ''}</div>
    <div class="card-top">
     <span class="card-status ${d.statusClass}">${d.fdaStatus}</span>
     <div class="drug-type-badge ${d.typeClass}">${d.type}</div>
     <div class="drug-name">${d.name}</div>
     <div class="drug-brand">${d.brand}</div>
     <div class="stats-row">
      <div class="stat-pill"><span class="num">${d.weightLoss}</span><span class="lbl">kilo kaybÄ±</span></div>
      <div class="stat-pill"><span class="num">${d.dosing.split(' ')[0]}</span><span class="lbl">${d.dosing.split(' ').slice(1).join(' ')}</span></div>
     </div>
    </div>
    <div class="card-details">
     <div class="detail-row"><span class="key">Mekanizma</span><span class="val">${d.mechanism}</span></div>
     <div class="detail-row"><span class="key">Kalp FaydasÄ±</span><span class="val">${d.heartBenefit}</span></div>
     <div class="detail-row"><span class="key">YaygÄ±n Yan Etkiler</span><span class="val">${d.commonSE}</span></div>
     <div class="detail-row"><span class="key">Klinik Ã‡alÄ±ÅŸma</span><span class="val">${d.trialName}</span></div>
     <div class="detail-row"><span class="key">Maliyet (ABD)</span><span class="val">${d.costUS}</span></div>
     <div class="detail-row"><span class="key">TÃ¼rkiye</span><span class="val">${d.costTR}</span></div>
    </div>
   </div>`;
 }).join('');
}

function shouldHide(d) {
 if (currentFilter === 'all') return false;
 if (currentFilter === 'approved') return d.phase !== 'approved';
 if (currentFilter === 'pipeline') return d.phase !== 'pipeline';
 if (currentFilter === 'injection') return d.route !== 'injection';
 if (currentFilter === 'oral') return d.route !== 'oral';
 return false;
}

function filterDrugs(filter, btn) {
 currentFilter = filter;
 document.querySelectorAll('.filter-btn').forEach(b => b.classList.remove('active'));
 btn.classList.add('active');
 renderCards();
 gtag('event','filter_drugs',{event_category:'GLP1_Tool',event_label:filter});
}

function toggleSelect(id) {
 if (selectedIds.includes(id)) {
  selectedIds = selectedIds.filter(x => x !== id);
 } else if (selectedIds.length < 3) {
  selectedIds.push(id);
 }
 updateCompareBar();
 renderCards();
 gtag('event','select_drug',{event_category:'GLP1_Tool',event_label:id});
}

function updateCompareBar() {
 const container = document.getElementById('selectedDrugs');
 container.innerHTML = selectedIds.map(id => {
  const d = DRUGS.find(x => x.id === id);
  return `<span class="drug-tag">${d.name} <span class="remove" onclick="event.stopPropagation();toggleSelect('${id}')">Ã—</span></span>`;
 }).join('');
 document.getElementById('compareBtn').disabled = selectedIds.length < 2;
}

// â”€â”€ COMPARISON TABLE â”€â”€
function showComparison() {
 const drugs = selectedIds.map(id => DRUGS.find(x => x.id === id));
 const fields = [
  ['Ä°laÃ§ AdÄ±','name'],['Marka','brand'],['Tip','type'],['Mekanizma','mechanism'],
  ['Kilo KaybÄ±','weightLoss'],['Dozaj','dosing'],['FDA Durumu','fdaStatus'],
  ['Kalp FaydasÄ±','heartBenefit'],['Etki BaÅŸlangÄ±cÄ±','onset'],['Tepe Kilo KaybÄ±','peakLoss'],
  ['YaygÄ±n Yan Etkiler','commonSE'],['Ciddi Yan Etkiler','seriousSE'],
  ['Kontrendikasyonlar','contraindications'],['Klinik Ã‡alÄ±ÅŸma','trialName'],
  ['KatÄ±lÄ±mcÄ± SayÄ±sÄ±','participants'],['Maliyet (ABD)','costUS'],['TÃ¼rkiye','costTR']
 ];

 let html = '<thead><tr><th>Ã–zellik</th>';
 drugs.forEach(d => html += `<th>${d.name}</th>`);
 html += '</tr></thead><tbody>';

 fields.forEach(([label, key]) => {
  html += `<tr><td class="row-label">${label}</td>`;
  drugs.forEach(d => {
   let cls = '';
   if (key === 'weightLoss') {
    const nums = drugs.map(dd => parseFloat(dd.weightLoss.replace(/[^0-9.]/g,'')));
    const max = Math.max(...nums);
    if (parseFloat(d.weightLoss.replace(/[^0-9.]/g,'')) === max) cls = 'winner';
   }
   html += `<td class="${cls}">${d[key]}</td>`;
  });
  html += '</tr>';
 });
 html += '</tbody>';
 document.getElementById('compareTable').innerHTML = html;
 document.getElementById('compareSection').classList.add('show');
 document.getElementById('compareSection').scrollIntoView({behavior:'smooth',block:'start'});
 gtag('event','compare_drugs',{event_category:'GLP1_Tool',event_label:selectedIds.join('_vs_')});
}

function hideComparison() {
 document.getElementById('compareSection').classList.remove('show');
}

// â”€â”€ QUIZ â”€â”€
let quizAnswers = {};

function quizAnswer(step, val) {
 quizAnswers[step] = val;
 const opts = document.querySelectorAll(`.quiz-step[data-step="${step}"] .quiz-opt`);
 opts.forEach(o => o.classList.remove('chosen'));
 event.currentTarget.classList.add('chosen');

 setTimeout(() => {
  const current = document.querySelector(`.quiz-step[data-step="${step}"]`);
  current.classList.remove('active');
  const nextStep = step < 4 ? step + 1 : 'result';
  const next = document.querySelector(`.quiz-step[data-step="${nextStep}"]`);
  next.classList.add('active');

  if (nextStep === 'result') showQuizResult();
 }, 400);
 gtag('event','quiz_answer',{event_category:'GLP1_Tool',event_label:`q${step}_${val}`});
}

function showQuizResult() {
 const a = quizAnswers;
 let rec, reason;

 // Logic tree
 if (a[1] === 'no') {
  // Oral preference
  if (a[3] === 'approved') {
   rec = DRUGS.find(d => d.id === 'oral-sema');
   reason = 'Enjeksiyon istemiyorsunuz ve onaylÄ± bir ilaÃ§ tercih ediyorsunuz. Oral Wegovy (semaglutide hapÄ±) 2025\'te FDA onayÄ± aldÄ± ve ~%15 kilo kaybÄ± saÄŸlÄ±yor.';
  } else {
   rec = DRUGS.find(d => d.id === 'orfor');
   reason = 'Oral tercih ve yeni nesil ilaÃ§lara aÃ§Ä±ksÄ±nÄ±z. Orforglipron peptid bazlÄ± olmayan ilk oral GLP-1 olarak Faz 3\'te ve ~%14 kilo kaybÄ± gÃ¶steriyor.';
  }
 } else if (a[2] === 'max-loss') {
  if (a[3] === 'approved') {
   if (a[4] === 'premium') {
    rec = DRUGS.find(d => d.id === 'tirze');
    reason = 'Maksimum kilo kaybÄ± istiyorsunuz. Tirzepatide (Zepbound), Ã§ift agonist mekanizmasÄ±yla ~%20-22 kilo kaybÄ± saÄŸlÄ±yor â€” onaylÄ± ilaÃ§lar arasÄ±nda en yÃ¼ksek.';
   } else {
    rec = DRUGS.find(d => d.id === 'sema24');
    reason = 'YÃ¼ksek etkinlikli, onaylÄ± bir ilaÃ§ arÄ±yorsunuz. Wegovy (semaglutide 2.4mg), ~%15 kilo kaybÄ± ve kanÄ±tlanmÄ±ÅŸ kalp koruma etkisiyle gÃ¼Ã§lÃ¼ bir seÃ§enek.';
   }
  } else {
   rec = DRUGS.find(d => d.id === 'retat');
   reason = 'Maksimum kilo kaybÄ± iÃ§in yeni nesil ilaÃ§lara aÃ§Ä±ksÄ±nÄ±z. Retatrutide, Ã¼Ã§lÃ¼ agonist mekanizmasÄ±yla Faz 2\'de ~%24 kilo kaybÄ± gÃ¶sterdi â€” ÅŸu ana kadarki en yÃ¼ksek oran.';
  }
 } else if (a[2] === 'heart') {
  rec = DRUGS.find(d => d.id === 'sema24');
  reason = 'Kalp saÄŸlÄ±ÄŸÄ± Ã¶nceliÄŸiniz. SELECT Ã§alÄ±ÅŸmasÄ±nda semaglutide 2.4mg, MACE olaylarÄ±nÄ± %20 azalttÄ± â€” kardiyovaskÃ¼ler korumada en gÃ¼Ã§lÃ¼ kanÄ±ta sahip GLP-1 ilacÄ±.';
 } else {
  // moderate
  if (a[4] === 'budget') {
   rec = DRUGS.find(d => d.id === 'sema1');
   reason = 'Orta dÃ¼zey kilo kaybÄ± ve diyabet kontrolÃ¼ istiyorsunuz. Ozempic (semaglutide 1mg) SGK kapsamÄ±nda olabilir ve ~%12 kilo kaybÄ± saÄŸlÄ±yor.';
  } else {
   rec = DRUGS.find(d => d.id === 'sema24');
   reason = 'Dengeli bir yaklaÅŸÄ±m arÄ±yorsunuz. Wegovy (semaglutide 2.4mg), hem iyi dÃ¼zeyde kilo kaybÄ± hem de kalp koruma etkisiyle kapsamlÄ± bir Ã§Ã¶zÃ¼m sunuyor.';
  }
 }

 document.getElementById('quizResult').innerHTML = `
  <h3>ğŸ¯ Size Ã–nerilen Ä°laÃ§</h3>
  <div class="rec-drug">${rec.name} (${rec.brand})</div>
  <div class="rec-reason">${reason}</div>
  <div style="background:var(--gray-50);border-radius:12px;padding:1rem;text-align:left;max-width:400px;margin:0 auto 1rem">
   <div class="detail-row"><span class="key">Kilo KaybÄ±</span><span class="val">${rec.weightLoss}</span></div>
   <div class="detail-row"><span class="key">Dozaj</span><span class="val">${rec.dosing}</span></div>
   <div class="detail-row"><span class="key">Durum</span><span class="val">${rec.fdaStatus}</span></div>
  </div>
  <p style="font-size:.8rem;color:var(--gray-400)">Bu Ã¶neri genel bilgilendirme amaÃ§lÄ±dÄ±r. Ä°laÃ§ seÃ§imi mutlaka hekiminizle birlikte yapÄ±lmalÄ±dÄ±r.</p>
  <div class="quiz-nav">
   <button class="restart-btn" onclick="restartQuiz()">ğŸ”„ Tekrar BaÅŸla</button>
  </div>
 `;
 gtag('event','quiz_result',{event_category:'GLP1_Tool',event_label:rec.id});
}

function restartQuiz() {
 quizAnswers = {};
 document.querySelectorAll('.quiz-step').forEach(s => s.classList.remove('active'));
 document.querySelectorAll('.quiz-opt').forEach(o => o.classList.remove('chosen'));
 document.querySelector('.quiz-step[data-step="1"]').classList.add('active');
}

// â”€â”€ INIT â”€â”€
renderCards();
updateCompareBar();
</script>
<script src="/scripts/odometer-counter.js"></script>
<script src="/scripts/premium-animations.js"></script>
</body>
</html>
